Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2019 · 10-Q
Revenue$187.10M$187.10M+59.5% vs Q2 2018 Net Income$21.38M$21.38M+51.3% vs Q2 2018 EPS Diluted$1.75$1.75+50.9% vs Q2 2018 Gross Profit$140,710,000+58.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$14,478,000−29.5% Free Cash Flowderived$11,950,000−39.4% Margins · derivedGross margin75.2%−0.5 pt vs Q2 2018
Operating margin14.6%+0.0 pt vs Q2 2018
Net margin11.4%−0.6 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 2, 2019 · 33 d after period end